These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24833095)

  • 1. Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma.
    Xie C; Fu L; Han Y; Li Q; Wang E
    Tumour Biol; 2014 Aug; 35(8):7921-7. PubMed ID: 24833095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of histone modification affecting
    Erfani M; Zamani M; Mokarram P
    Gastroenterol Hepatol Bed Bench; 2022; 15(1):32-38. PubMed ID: 35611248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic insights into the regulatory function of ARID1A in colon cancer cells.
    Aluksanasuwan S; Somsuan K; Wanna-Udom S; Roytrakul S; Morchang A; Rongjumnong A; Sakulsak N
    Oncol Lett; 2024 Aug; 28(2):392. PubMed ID: 38966585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition.
    Samartzis EP; Gutsche K; Dedes KJ; Fink D; Stucki M; Imesch P
    Oncotarget; 2014 Jul; 5(14):5295-303. PubMed ID: 24979463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
    Shen J; Peng Y; Wei L; Zhang W; Yang L; Lan L; Kapoor P; Ju Z; Mo Q; Shih IeM; Uray IP; Wu X; Brown PH; Shen X; Mills GB; Peng G
    Cancer Discov; 2015 Jul; 5(7):752-67. PubMed ID: 26069190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.
    Chou A; Toon CW; Clarkson A; Sioson L; Houang M; Watson N; DeSilva K; Gill AJ
    Hum Pathol; 2014 Aug; 45(8):1697-703. PubMed ID: 24925223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
    Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH
    World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
    Bitler BG; Aird KM; Garipov A; Li H; Amatangelo M; Kossenkov AV; Schultz DC; Liu Q; Shih IeM; Conejo-Garcia JR; Speicher DW; Zhang R
    Nat Med; 2015 Mar; 21(3):231-8. PubMed ID: 25686104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
    Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
    Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.
    Guan B; Rahmanto YS; Wu RC; Wang Y; Wang Z; Wang TL; Shih IeM
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24899687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
    Williamson CT; Miller R; Pemberton HN; Jones SE; Campbell J; Konde A; Badham N; Rafiq R; Brough R; Gulati A; Ryan CJ; Francis J; Vermulen PB; Reynolds AR; Reaper PM; Pollard JR; Ashworth A; Lord CJ
    Nat Commun; 2016 Dec; 7():13837. PubMed ID: 27958275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.
    Luo Q; Wu X; Zhang Y; Shu T; Ding F; Chen H; Zhao P; Chang W; Zhu X; Liu Z
    Cancer Lett; 2018 Jul; 427():9-17. PubMed ID: 29660381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
    J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ARID1A mutation in gastric cancer and its significance for treatment.
    Lu S; Duan R; Cong L; Song Y
    Cancer Cell Int; 2023 Nov; 23(1):296. PubMed ID: 38008753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis.
    Abramczyk J; Milkiewicz M; Hula B; Milkiewicz P; Kempinska-Podhorodecka A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality.
    Yakovlev VA; Sullivan SA; Fields EC; Temkin SM
    Front Oncol; 2023; 13():1124147. PubMed ID: 36910637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of ARID1A variations in colorectal cancer: a collaborative review.
    Zhao S; Wu W; Jiang Z; Tang F; Ding L; Xu W; Ruan L
    Mol Med; 2022 Apr; 28(1):42. PubMed ID: 35421925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma.
    Tessiri S; Techasen A; Kongpetch S; Namjan A; Loilome W; Chan-On W; Thanan R; Jusakul A
    PeerJ; 2022; 10():e12750. PubMed ID: 35070505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of
    Xu S; Tang C
    Front Oncol; 2021; 11():745187. PubMed ID: 34671561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells.
    Kantapan J; Paksee S; Duangya A; Sangthong P; Roytrakul S; Krobthong S; Suttana W; Dechsupa N
    BMC Complement Med Ther; 2021 Jul; 21(1):189. PubMed ID: 34217266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.